Nityr

Active Ingredient(s): Nitisinone
FDA Approved: * July 26, 2017
Pharm Company: * CYCLE PHARMS LTD
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Nityr Overview

Nitisinone (INN), also known as NTBC (an abbreviation of its full chemical name) is a medication used to slow the effects of hereditary tyrosinemia type 1. Since its first use for this indication in 1991, it has replaced liver transplantation as the first-line treatment for this rare condition. It is also being studied in the related condition alkaptonuria. It is marketed under the brand name Orfadin by the company Swedish Orphan Biovitrum (Sobi); it was first brought to market by Swedish Orp...

Read more Nityr Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nitisinone

Recent Nityr Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Nitisinone
  • Capsule: 10mg, 20mg, 2mg, 5mg
  • Suspension: 4mg/ml
  • Tablet: 10mg, 2mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nityr: (3 results)

Sorted by National Drug Code
  • 70709-000 Nityr 10 mg Oral Tablet by Cycle Pharmaceuticals Ltd.
  • 70709-002 Nityr 2 mg Oral Tablet by Cycle Pharmaceuticals Ltd.
  • 70709-005 Nityr 5 mg Oral Tablet by Cycle Pharmaceuticals Ltd.

Other drugs which contain Nitisinone or a similar ingredient: (2 results)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 18 October 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.